Predictive genetic testing searches for genetic changes, or mutations, that are linked to disease. These tests are done before you show any signs of a disease.?
This report contains market size and forecasts of Predictive and Presymptomatic Testing in Global, including the following market information:
Global Predictive and Presymptomatic Testing Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Predictive and Presymptomatic Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Presymptomatic Testing Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Predictive and Presymptomatic Testing include 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc., Direct Laboratory Services LLC (DirectLabs), Gene by Gene Ltd., Genomic Diagnostics, Mapmygenome and Myriad Genetics, Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Predictive and Presymptomatic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Predictive and Presymptomatic Testing Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Predictive and Presymptomatic Testing Market Segment Percentages, by Type, 2022 (%)
Presymptomatic Testing
Predispositional Testing
Global Predictive and Presymptomatic Testing Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Predictive and Presymptomatic Testing Market Segment Percentages, by Application, 2022 (%)
Breast and Ovarian Cancer
Colorectal Cancer
Alzheimer's Disease
Multiple Endocrine Neoplasia Type 2
Haemochromatosis
Global Predictive and Presymptomatic Testing Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Predictive and Presymptomatic Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Predictive and Presymptomatic Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Predictive and Presymptomatic Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
23andMe, Inc.
Abbott Molecular, Inc.
BioAxis DNA Research Centre Private Limited
Color Genomics, Inc.
Direct Laboratory Services LLC (DirectLabs)
Gene by Gene Ltd.
Genomic Diagnostics
Mapmygenome
Myriad Genetics, Inc.
Pathway Genomics Corporation
Positive Bioscience, Inc.
Quest Diagnostics, Inc.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Predictive and Presymptomatic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Predictive and Presymptomatic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Predictive and Presymptomatic Testing Overall Market Size
2.1 Global Predictive and Presymptomatic Testing Market Size: 2022 VS 2030
2.2 Global Predictive and Presymptomatic Testing Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Predictive and Presymptomatic Testing Players in Global Market
3.2 Top Global Predictive and Presymptomatic Testing Companies Ranked by Revenue
3.3 Global Predictive and Presymptomatic Testing Revenue by Companies
3.4 Top 3 and Top 5 Predictive and Presymptomatic Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Predictive and Presymptomatic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Predictive and Presymptomatic Testing Players in Global Market
3.6.1 List of Global Tier 1 Predictive and Presymptomatic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Predictive and Presymptomatic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Predictive and Presymptomatic Testing Market Size Markets, 2022 & 2030
4.1.2 Presymptomatic Testing
4.1.3 Predispositional Testing
4.2 By Type - Global Predictive and Presymptomatic Testing Revenue & Forecasts
4.2.1 By Type - Global Predictive and Presymptomatic Testing Revenue, 2018-2023
4.2.2 By Type - Global Predictive and Presymptomatic Testing Revenue, 2023-2030
4.2.3 By Type - Global Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Predictive and Presymptomatic Testing Market Size, 2022 & 2030
5.1.2 Breast and Ovarian Cancer
5.1.3 Colorectal Cancer
5.1.4 Alzheimer's Disease
5.1.5 Multiple Endocrine Neoplasia Type 2
5.1.6 Haemochromatosis
5.2 By Application - Global Predictive and Presymptomatic Testing Revenue & Forecasts
5.2.1 By Application - Global Predictive and Presymptomatic Testing Revenue, 2018-2023
5.2.2 By Application - Global Predictive and Presymptomatic Testing Revenue, 2023-2030
5.2.3 By Application - Global Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Predictive and Presymptomatic Testing Market Size, 2022 & 2030
6.2 By Region - Global Predictive and Presymptomatic Testing Revenue & Forecasts
6.2.1 By Region - Global Predictive and Presymptomatic Testing Revenue, 2018-2023
6.2.2 By Region - Global Predictive and Presymptomatic Testing Revenue, 2023-2030
6.2.3 By Region - Global Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Predictive and Presymptomatic Testing Revenue, 2018-2030
6.3.2 US Predictive and Presymptomatic Testing Market Size, 2018-2030
6.3.3 Canada Predictive and Presymptomatic Testing Market Size, 2018-2030
6.3.4 Mexico Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Predictive and Presymptomatic Testing Revenue, 2018-2030
6.4.2 Germany Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.3 France Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.4 U.K. Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.5 Italy Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.6 Russia Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.7 Nordic Countries Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.8 Benelux Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Predictive and Presymptomatic Testing Revenue, 2018-2030
6.5.2 China Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5.3 Japan Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5.4 South Korea Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5.5 Southeast Asia Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5.6 India Predictive and Presymptomatic Testing Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Predictive and Presymptomatic Testing Revenue, 2018-2030
6.6.2 Brazil Predictive and Presymptomatic Testing Market Size, 2018-2030
6.6.3 Argentina Predictive and Presymptomatic Testing Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Predictive and Presymptomatic Testing Revenue, 2018-2030
6.7.2 Turkey Predictive and Presymptomatic Testing Market Size, 2018-2030
6.7.3 Israel Predictive and Presymptomatic Testing Market Size, 2018-2030
6.7.4 Saudi Arabia Predictive and Presymptomatic Testing Market Size, 2018-2030
6.7.5 UAE Predictive and Presymptomatic Testing Market Size, 2018-2030
7 Players Profiles
7.1 23andMe, Inc.
7.1.1 23andMe, Inc. Corporate Summary
7.1.2 23andMe, Inc. Business Overview
7.1.3 23andMe, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.1.4 23andMe, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.1.5 23andMe, Inc. Key News
7.2 Abbott Molecular, Inc.
7.2.1 Abbott Molecular, Inc. Corporate Summary
7.2.2 Abbott Molecular, Inc. Business Overview
7.2.3 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.2.4 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.2.5 Abbott Molecular, Inc. Key News
7.3 BioAxis DNA Research Centre Private Limited
7.3.1 BioAxis DNA Research Centre Private Limited Corporate Summary
7.3.2 BioAxis DNA Research Centre Private Limited Business Overview
7.3.3 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Major Product Offerings
7.3.4 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.3.5 BioAxis DNA Research Centre Private Limited Key News
7.4 Color Genomics, Inc.
7.4.1 Color Genomics, Inc. Corporate Summary
7.4.2 Color Genomics, Inc. Business Overview
7.4.3 Color Genomics, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.4.4 Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.4.5 Color Genomics, Inc. Key News
7.5 Direct Laboratory Services LLC (DirectLabs)
7.5.1 Direct Laboratory Services LLC (DirectLabs) Corporate Summary
7.5.2 Direct Laboratory Services LLC (DirectLabs) Business Overview
7.5.3 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Major Product Offerings
7.5.4 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.5.5 Direct Laboratory Services LLC (DirectLabs) Key News
7.6 Gene by Gene Ltd.
7.6.1 Gene by Gene Ltd. Corporate Summary
7.6.2 Gene by Gene Ltd. Business Overview
7.6.3 Gene by Gene Ltd. Predictive and Presymptomatic Testing Major Product Offerings
7.6.4 Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.6.5 Gene by Gene Ltd. Key News
7.7 Genomic Diagnostics
7.7.1 Genomic Diagnostics Corporate Summary
7.7.2 Genomic Diagnostics Business Overview
7.7.3 Genomic Diagnostics Predictive and Presymptomatic Testing Major Product Offerings
7.7.4 Genomic Diagnostics Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.7.5 Genomic Diagnostics Key News
7.8 Mapmygenome
7.8.1 Mapmygenome Corporate Summary
7.8.2 Mapmygenome Business Overview
7.8.3 Mapmygenome Predictive and Presymptomatic Testing Major Product Offerings
7.8.4 Mapmygenome Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.8.5 Mapmygenome Key News
7.9 Myriad Genetics, Inc.
7.9.1 Myriad Genetics, Inc. Corporate Summary
7.9.2 Myriad Genetics, Inc. Business Overview
7.9.3 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.9.4 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.9.5 Myriad Genetics, Inc. Key News
7.10 Pathway Genomics Corporation
7.10.1 Pathway Genomics Corporation Corporate Summary
7.10.2 Pathway Genomics Corporation Business Overview
7.10.3 Pathway Genomics Corporation Predictive and Presymptomatic Testing Major Product Offerings
7.10.4 Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.10.5 Pathway Genomics Corporation Key News
7.11 Positive Bioscience, Inc.
7.11.1 Positive Bioscience, Inc. Corporate Summary
7.11.2 Positive Bioscience, Inc. Business Overview
7.11.3 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.11.4 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.11.5 Positive Bioscience, Inc. Key News
7.12 Quest Diagnostics, Inc.
7.12.1 Quest Diagnostics, Inc. Corporate Summary
7.12.2 Quest Diagnostics, Inc. Business Overview
7.12.3 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.12.4 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.12.5 Quest Diagnostics, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Predictive and Presymptomatic Testing Market Opportunities & Trends in Global Market
Table 2. Predictive and Presymptomatic Testing Market Drivers in Global Market
Table 3. Predictive and Presymptomatic Testing Market Restraints in Global Market
Table 4. Key Players of Predictive and Presymptomatic Testing in Global Market
Table 5. Top Predictive and Presymptomatic Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Predictive and Presymptomatic Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Predictive and Presymptomatic Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Predictive and Presymptomatic Testing Product Type
Table 9. List of Global Tier 1 Predictive and Presymptomatic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Predictive and Presymptomatic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Predictive and Presymptomatic Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Predictive and Presymptomatic Testing Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Predictive and Presymptomatic Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Predictive and Presymptomatic Testing Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Predictive and Presymptomatic Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Predictive and Presymptomatic Testing Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2023-2030
Table 30. 23andMe, Inc. Corporate Summary
Table 31. 23andMe, Inc. Predictive and Presymptomatic Testing Product Offerings
Table 32. 23andMe, Inc. Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 33. Abbott Molecular, Inc. Corporate Summary
Table 34. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product Offerings
Table 35. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 36. BioAxis DNA Research Centre Private Limited Corporate Summary
Table 37. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product Offerings
Table 38. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 39. Color Genomics, Inc. Corporate Summary
Table 40. Color Genomics, Inc. Predictive and Presymptomatic Testing Product Offerings
Table 41. Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 42. Direct Laboratory Services LLC (DirectLabs) Corporate Summary
Table 43. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product Offerings
Table 44. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 45. Gene by Gene Ltd. Corporate Summary
Table 46. Gene by Gene Ltd. Predictive and Presymptomatic Testing Product Offerings
Table 47. Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 48. Genomic Diagnostics Corporate Summary
Table 49. Genomic Diagnostics Predictive and Presymptomatic Testing Product Offerings
Table 50. Genomic Diagnostics Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 51. Mapmygenome Corporate Summary
Table 52. Mapmygenome Predictive and Presymptomatic Testing Product Offerings
Table 53. Mapmygenome Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 54. Myriad Genetics, Inc. Corporate Summary
Table 55. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product Offerings
Table 56. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 57. Pathway Genomics Corporation Corporate Summary
Table 58. Pathway Genomics Corporation Predictive and Presymptomatic Testing Product Offerings
Table 59. Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 60. Positive Bioscience, Inc. Corporate Summary
Table 61. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product Offerings
Table 62. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
Table 63. Quest Diagnostics, Inc. Corporate Summary
Table 64. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product Offerings
Table 65. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Predictive and Presymptomatic Testing Segment by Type in 2022
Figure 2. Predictive and Presymptomatic Testing Segment by Application in 2022
Figure 3. Global Predictive and Presymptomatic Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Predictive and Presymptomatic Testing Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Predictive and Presymptomatic Testing Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Predictive and Presymptomatic Testing Revenue in 2022
Figure 8. By Type - Global Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
Figure 9. By Application - Global Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
Figure 10. By Region - Global Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
Figure 11. By Country - North America Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
Figure 12. US Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
Figure 16. Germany Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 17. France Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
Figure 24. China Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 28. India Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
Figure 30. Brazil Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
Figure 33. Turkey Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Predictive and Presymptomatic Testing Revenue, (US$, Mn), 2018-2030
Figure 37. 23andMe, Inc. Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Genomic Diagnostics Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Mapmygenome Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
